Vistagen Therapeutics, Inc. (VTGN)
0.5632
+0.06
(+11.52%)
USD |
NASDAQ |
Feb 06, 16:00
0.545
-0.02
(-3.23%)
Pre-Market: 09:22
Vistagen Therapeutics Total Liabilities (Quarterly) : 14.59M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| XOMA Royalty Corp. | 155.19M |
| Omeros Corp. | 406.18M |
| GeoVax Labs, Inc. | 1.824M |
| Daré Bioscience, Inc. | 27.89M |
| Spero Therapeutics, Inc. | 27.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.93M |
| Shareholders Equity (Quarterly) | 66.34M |
| Debt to Equity Ratio | 0.0281 |
| Current Ratio | 5.785 |
| Net Debt Paydown Yield | 0.04% |